Purpose: To determine the agents, co-morbidities, and intestinal anatomical abnormalities that contribute to the improved capsule endoscopy (CE) completion rates (CR) starting at 2010 to present in a Veteran's Administration single-center tertiary care medical center. Methods: A retrospective analysis of 53 patients undergoing CE, aged 26-88 years, median age 65 years, >97% male, from 2007 through 2013. CR defined as capsule completing the transit to the cecum. Small bowel transit time (SBTT) defined as the capsule's total time in the small intestine. Results: In our study of 53 patients undergoing CE, the most common indications were obscure gastrointestinal bleed (38%), iron-deficiency anemia (34%), diarrhea (16%), abdominal pain (10%) and suspected Crohn's disease (10%). The three most common findings were angioectasia (33.3%), ulcerations (23.8%) and active bleeding (16.7%). Significant improvement in outpatient EGD-assisted CE was detected starting from 2010 to the present compared to previous years (94% vs. 60%, p=0.034). EGD-assist CE showed a significantly improved CR compared to conventional CE without endoscopy assisted CE placement (94% vs. 38%, p=0.018, 2010-present). Patients who underwent conventional CE and failed to have complete capsule transit consisted of a marked diabetic population (57% vs. 0%, p=0.015). The significantly improved CR amongst the EGD-assisted CE in 2010 to present showed a population which used significantly increased opiates (50% vs. 0%, p=0.0015) compared to years prior. Among the patients from all years who successfully completed capsule transit to the cecum, there was a marked use of narcotic agents (35% vs. 0%, p=0.0024) compared to those whose capsules did not complete their transit to the cecum. Amongst patients who had successful CR there was a trend towards shorter SBTT in the patient population taking narcotics, though the trend was not statistically significant (201 vs. 223 min, p=0.44). Other factors including promotility (i.e., metoclopramide), and bowel cleansing regimen (GoLYTELY®), co-morbidities such as Crohn's disease, and anatomical abnormalities were not found to have statistical significance contributing to the improved CR from 2010 to the present. Conclusion: Long known for contributing to intestinal hypo-motility, we report opiate use markedly improved CR with evidence that SBTT may be shortened in patients undergoing EGD-assisted CE in the clinical setting. In contrast, conventional CE remained inferior to endoscopy-assisted CE with lower CR. Future prospective studies are needed to further understand this novel and intriguing relationship. Disclosure - Dr. Jackson, VA GI physician Dr. Basseri, VA GI fellow.
Read full abstract